Chen Yu, TCG Crossover funds disclose 6.9% Perspective Therapeutics (CATX) stake

Rhea-AI Filing Summary

Perspective Therapeutics, Inc. (CATX) received a Schedule 13G reporting a significant but non-controlling ownership position by TCG Crossover funds and Chen Yu. The filing shows that Chen Yu may be deemed to beneficially own 7,915,567 shares of common stock, equal to 6.9% of the company’s 113,914,078 shares of common stock outstanding.

The holdings are split between TCG Crossover Fund II, L.P. and TCG Crossover Fund III, L.P., which each report beneficial ownership of 3,957,784 and 3,957,783 shares, respectively, or 3.5% of the class each. The reporting parties certify the shares were not acquired to change or influence control of Perspective Therapeutics.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Perspective Therapeutics, Inc.

(Name of Issuer)

Common Stock, $0.001 par value

(Title of Class of Securities)

46489V302

(CUSIP Number)

02/03/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 46489V302

1

Names of Reporting Persons

TCG Crossover GP II, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 3,957,784.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 3,957,784.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,957,784.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

3.5 %

12

Type of Reporting Person (See Instructions)

OO

Comment for Type of Reporting Person: These securities are held of record by TCG Crossover II (as defined in Item 2(a) below). TCG Crossover GP II (as defined in Item 2(a) below) is the general partner of TCG Crossover II and may be deemed to have voting, investment, and dispositive power with respect to these securities. Chen Yu is the sole managing member of TCG Crossover GP II and may be deemed to share voting, investment and dispositive power with respect to these securities. Based on 113,914,078 shares of Common Stock, as follows: (a) 74,337,990 shares of Common Stock outstanding as of November 6, 2025 as reported by the Issuer (as defined in Item 1(a) below) in its Quarterly Report on Form 10-Q, filed with the United States Securities and Exchange Commission (the Commission) on November 10, 2025 (the Form 10-Q), plus (b) 39,576,088 shares of Common Stock issued in an underwritten offering that closed on February 3, 2026, as reported in the Issuer's Current Report on Form 8-K, filed with the Commission on February 3, 2026 (the Offering).

SCHEDULE 13G

CUSIP No. 46489V302

1

Names of Reporting Persons

TCG Crossover Fund II, L.P.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 3,957,784.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 3,957,784.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,957,784.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

3.5 %

12

Type of Reporting Person (See Instructions)

PN

Comment for Type of Reporting Person: These securities are held of record by TCG Crossover II. TCG Crossover GP II is the general partner of TCG Crossover II and may be deemed to have voting, investment, and dispositive power with respect to these securities. Chen Yu is the sole managing member of TCG Crossover GP II and may be deemed to share voting, investment and dispositive power with respect to these securities. Based on 113,914,078 shares of Common Stock, as follows: (a) 74,337,990 shares of Common Stock outstanding as of November 6, 2025 as reported by the Issuer in the Form 10-Q, plus (b) 35,576,088 shares of Common Stock issued in the Offering.

SCHEDULE 13G

CUSIP No. 46489V302

1

Names of Reporting Persons

TCG Crossover GP III, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 3,957,783.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 3,957,783.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,957,783.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

3.5 %

12

Type of Reporting Person (See Instructions)

OO

Comment for Type of Reporting Person: These securities are held of record by TCG Crossover III (as defined in Item 2(a) below). TCG Crossover GP III (as defined in Item 2(a) below) is the general partner of TCG Crossover III and may be deemed to have voting, investment, and dispositive power with respect to these securities. Chen Yu is the sole managing member of TCG Crossover GP III and may be deemed to share voting, investment and dispositive power with respect to these securities. Based on 113,914,078 shares of Common Stock, as follows: (a) 74,337,990 shares of Common Stock outstanding as of November 6, 2025 as reported by the Issuer in the Form 10-Q, plus (b) 35,576,088 shares of Common Stock issued in the Offering.

SCHEDULE 13G

CUSIP No. 46489V302

1

Names of Reporting Persons

TCG Crossover Fund III, L.P.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 3,957,783.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 3,957,783.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,957,783.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

3.5 %

12

Type of Reporting Person (See Instructions)

PN

Comment for Type of Reporting Person: These securities are held of record by TCG Crossover III. TCG Crossover GP III is the general partner of TCG Crossover III and may be deemed to have voting, investment, and dispositive power with respect to these securities. Chen Yu is the sole managing member of TCG Crossover GP III and may be deemed to share voting, investment and dispositive power with respect to these securities. Based on 113,914,078 shares of Common Stock, as follows: (a) 74,337,990 shares of Common Stock outstanding as of November 6, 2025 as reported by the Issuer in the Form 10-Q, plus (b) 39,576,088 shares of Common Stock issued in the Offering.

SCHEDULE 13G

CUSIP No. 46489V302

1

Names of Reporting Persons

Chen Yu

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 7,915,567.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 7,915,567.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

7,915,567.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

6.9 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: Consists of (i) 3,957,784 shares of Common Stock held of record by TCG Crossover II and (ii) 3,957,783 shares of Common Stock held of record by TCG Crossover III. TCG Crossover GP II is the general partner of TCG Crossover II and may be deemed to have voting, investment, and dispositive power with respect to the securities held of record by TCG Crossover II. TCG Crossover GP III is the general partner of TCG Crossover III and may be deemed to have voting, investment, and dispositive power with respect to the securities held of record by TCG Crossover III. Chen Yu is the sole managing member of each of TCG Crossover GP II and TCG Crossover GP III and may be deemed to share voting, investment and dispositive power with respect to the securities held of record by TCG Crossover II and TCG Crossover III. Based on 113,914,078 shares of Common Stock, as follows: (a) 74,337,990 shares of Common Stock outstanding as of November 6, 2025 as reported by the Issuer in the Form 10-Q, plus (b) 39,576,088 shares of Common Stock issued in the Offering.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Perspective Therapeutics, Inc.
(b)	Address of issuer's principal executive offices: 2401 Elliot Avenue, Suite 320, Seattle, WA 98121
Item 2.
(a)	Name of person filing: This joint statement on Schedule 13G is being filed by TCG Crossover Fund II, L.P. (TCG Crossover II), TCG Crossover GP II, LLC (TCG Crossover GP II), TCG Crossover Fund III, L.P. (TCG Crossover III) and TCG Crossover GP III, LLC (TCG Crossover GP III and together with TCG Crossover II, TCG Crossover GP II and TCG Crossover III, the Reporting Entities) and Chen Yu (the Reporting Individual). The Reporting Entities and the Reporting Individual are collectively referred to as the Reporting Persons. The Reporting Persons expressly disclaim status as a group for purposes of this Schedule 13G. The agreement among the Reporting Persons to file jointly in accordance with the provisions of Rule 13d-1(k)(1) under the Act is attached to this Statement as Exhibit 1. Other than those securities reported herein as being held directly by such Reporting Person, each Reporting Person disclaims beneficial ownership of all securities reported in this Statement except to the extent of such Reporting Person's pecuniary interest therein.
(b)	Address or principal business office or, if none, residence: The address of the principal business office of each Reporting Person is 245 Lytton Ave., Suite 350, Palo Alto, CA 94301.
(c)	Citizenship: TCG Crossover GP II and TCG Crossover GP III are each a limited liability company organized under the laws of the State of Delaware. TCG Crossover II and TCG Crossover III are each a limited partnership organized under the laws of the State of Delaware. The Reporting Individual is a citizen of the United States of America.
(d)	Title of class of securities: Common Stock, $0.001 par value
(e)	CUSIP No.: 46489V302
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: See Row 9 of the cover page for each Reporting Person and the corresponding comments.
(b)	Percent of class: See Row 11 of the cover page for each Reporting Person and the corresponding comments.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: See Row 5 of the cover page for each Reporting Person and the corresponding comments.
	(ii) Shared power to vote or to direct the vote: See Row 6 of the cover page for each Reporting Person and the corresponding comments.
	(iii) Sole power to dispose or to direct the disposition of: See Row 7 of the cover page for each Reporting Person and the corresponding comments.
	(iv) Shared power to dispose or to direct the disposition of: See Row 8 of the cover page for each Reporting Person and the corresponding comments.
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. Under certain circumstances set forth in the limited partnership agreements of TCG Crossover II and TCG Crossover III and the limited liability company agreements of TCG Crossover GP II and TCG Crossover GP III, the general and limited partners or members, as the case may be, of each of such entities may be deemed to have the right to receive dividends from, or the proceeds from, the sale of securities of the Issuer owned by each such entity of which they are a partner or member, as the case may be.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

TCG Crossover GP II, LLC

Signature:	/s/ Craig Skaling
Name/Title:	Craig Skaling, Authorized Signatory
Date:	02/06/2026

TCG Crossover Fund II, L.P.

Signature:	/s/ Craig Skaling
Name/Title:	Craig Skaling, Authorized Signatory
Date:	02/06/2026

TCG Crossover GP III, LLC

Signature:	/s/ Craig Skaling
Name/Title:	Craig Skaling, Authorized Signatory
Date:	02/06/2026

TCG Crossover Fund III, L.P.

Signature:	/s/ Craig Skaling
Name/Title:	Craig Skaling, Authorized Signatory
Date:	02/06/2026

Chen Yu

Signature:	/s/ Craig Skaling
Name/Title:	Craig Skaling, as Attorney-in-Fact for Chen Yu
Date:	02/06/2026

Comments accompanying signature: Exhibit 1: Joint Filing Agreement

FAQ

What ownership stake does Chen Yu report in Perspective Therapeutics (CATX)?

Chen Yu reports beneficial ownership of 7,915,567 shares of Perspective Therapeutics common stock, representing 6.9% of the outstanding class. This stake is held through TCG Crossover Fund II, L.P. and TCG Crossover Fund III, L.P., where Chen Yu controls the general partners.

How many Perspective Therapeutics (CATX) shares do the TCG Crossover funds hold?

TCG Crossover Fund II, L.P. reports 3,957,784 shares, and TCG Crossover Fund III, L.P. reports 3,957,783 shares of Perspective Therapeutics common stock. Each position represents 3.5% of the outstanding class, with shared voting and dispositive power reported for these holdings.

What percentage of Perspective Therapeutics does TCG Crossover collectively own?

Collectively, the TCG Crossover funds report beneficial ownership that results in Chen Yu being deemed to own 6.9% of Perspective Therapeutics’ common stock. The filing aggregates positions from TCG Crossover Fund II, L.P. and TCG Crossover Fund III, L.P. under Chen Yu’s shared control.

How many Perspective Therapeutics (CATX) shares are used as the ownership base in this Schedule 13G?

The reported ownership percentages are based on 113,914,078 shares of Perspective Therapeutics common stock. This consists of 74,337,990 shares outstanding as of November 6, 2025, plus 39,576,088 shares issued in an underwritten offering that closed on February 3, 2026.

Is the TCG Crossover and Chen Yu stake in Perspective Therapeutics for control purposes?

No. The Schedule 13G explicitly certifies the securities were not acquired and are not held for the purpose or effect of changing or influencing control of Perspective Therapeutics. The filing characterizes the ownership as passive under the relevant SEC rules.

Who signed the Schedule 13G for the TCG Crossover entities and Chen Yu?

The Schedule 13G was signed by Craig Skaling as Authorized Signatory for each TCG Crossover entity and as Attorney-in-Fact for Chen Yu on February 6, 2026. This signature certifies the accuracy and completeness of the ownership information reported.